Aspirin combined with Fufang Danshen Diwan was significantly more effective than aspirin alone at alleviating angina and improving ECG results (OR 2.45; 95% CI 1.95-3.08).
Meta-Analysis (n=1,367)
Does aspirin in combination with Fufang Danshen Diwan improve clinical outcomes and lipid profiles compared to aspirin alone in patients with coronary heart disease?
The combination of aspirin and Fufang Danshen Diwan may be more effective than aspirin alone for alleviating angina, improving ECG results, and optimizing lipid profiles in patients with coronary heart disease.
Odds Ratio: 2.45 (95% CI 1.95–3.08)
BACKGROUND/AIMS: Coronary heart disease is characterized by vascular stenosis or occlusion resulting in myocardial ischemia, hypoxia and necrosis. In China, the combination of aspirin and Fufang Danshen Diwan (FDD), a traditional Chinese medicine formula, has been suggested in the treatment of coronary heart disease. There have been several studies comparing the effectiveness of aspirin alone and in combination with FDD to treat coronary artery disease; however, it remains unclear whether combined aspirin therapy is superior. This study was thus designed to clarify this issue through a systematic review and meta-analysis. METHODS: Databases including PubMed, EMBASE, China National Knowledge Infrastructure (CNKI) database, Wanfang Data and VIP Information were searched. Papers were reviewed systematically by two researchers and analyzed using Cochrane software Revman 5.1. RESULTS: Fourteen randomized controlled trials enrolling 1367 subjects were included. Meta-analyses revealed that aspirin in combination with FDD was significantly more effective at alleviating angina pectoris and improving electrocardiogram (ECG) results relative to aspirin therapy alone, reflected by the summary effects for the clinical markedly effective (OR = 2.45; 95% CI 1.95-3.08) and the total effective (OR = 3.92; 95% CI 2.87-5.36) rates. In addition, combined aspirin and FDD was significantly more efficacious than aspirin monotherapy at improving blood lipid levels, as indicated by the following outcomes: 1) reduction of TC level (SMD -1.12; 95% CI -1.49 to -0.76); 2) reduction of TG level (SMD -0.94; 95% CI -1.15 to -0.74); 3) reduction of LDL level (SMD -0.68; 95% CI -0.88 to -0.48); and 4) improvement of HDL level (SMD 0.52; 95% CI 0.04 to 0.99 ). No serious adverse events were reported in any of the included trials. CONCLUSION: The present meta-analysis demonstrated that aspirin in combination with FDD was more effective than aspirin alone for treating coronary heart disease. More full-scale randomized clinical trials with reliable designs are recommended to further evaluate the clinical benefits and long-term effectiveness of FDD for the treatment of coronary heart disease.
Huang et al. (Fri,) conducted a meta-analysis in Coronary heart disease (n=1,367). Aspirin in combination with Fufang Danshen Diwan (FDD) vs. Aspirin alone was evaluated on Clinical markedly effective rate (alleviating angina pectoris and improving ECG results) (OR 2.45, 95% CI 1.95-3.08). Aspirin combined with Fufang Danshen Diwan was significantly more effective than aspirin alone at alleviating angina and improving ECG results (OR 2.45; 95% CI 1.95-3.08).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: